Literature DB >> 15030423

Electrophysiologic effects of salbutamol, a beta2-selective agonist.

Per Insulander1, Anders Juhlin-Dannfelt, Ulla Freyschuss, Hans Vallin.   

Abstract

INTRODUCTION: A positive chronotropic effect of beta2 stimulation is well known. Case reports of ventricular arrhythmias during beta2-inhalation therapy have been published. The aim of this study was to asses the overall electrophysiologic effects of the beta2-agonist salbutamol. METHODS AND
RESULTS: Electrophysiologic and hemodynamic variables were measured in 10 healthy volunteers during atrial pacing at baseline and during infusion of salbutamol at two different rates (0.1 and 0.2 microg/kg/min). To characterize beta2-agonist effects, a comparison was made with the beta1-selective agonist dobutamine. Salbutamol infusion produced significant changes in electrophysiologic properties in both myocardial and nodal tissues, with significantly greater effects on nodal properties. The proportional decreases in AV nodal parameters were more pronounced than in the sinus node (P < 0.001). An interesting result was a significant increase in the duration of the QS interval, which in the presence of an unchanged His-Purkinje conduction (HV) represents slower depolarization of the ventricle. QT dispersion also increased.
CONCLUSION: Infusion of salbutamol results in significant electrophysiologic effects on most heart structures, proportionally most pronounced in the AV node. Discordant effects on ventricular conduction, which slowed, and the refractoriness of the ventricular myocardium, which shortened, were seen. QT dispersion was increased.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15030423     DOI: 10.1046/j.1540-8167.2004.03105.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  8 in total

Review 1.  Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease.

Authors:  Kate McKeage
Journal:  Drugs       Date:  2012-03-05       Impact factor: 9.546

2.  Safety of bronchodilator reversibility test in elderly subjects: a prospective study.

Authors:  Anna Dor-Wojnarowska; Anna Parużyńska; Aleksandra Kulczak; Marta Majewska-Pulsakowska; Małgorzata Szymala-Pędzik; Zbigniew Machaj; Małgorzata Sobieszczańska; Małgorzata Poręba
Journal:  Postepy Dermatol Alergol       Date:  2020-02-19       Impact factor: 1.837

3.  Atrial flutter versus atrial fibrillation in a general population: differences in comorbidities associated with their respective onset.

Authors:  Ravi K Mareedu; Ihab B Abdalrahman; Kodlipet C Dharmashankar; Juan F Granada; Po-Huang Chyou; Param P Sharma; Peter N Smith; John J Hayes; Robert T Greenlee; Humberto Vidaillet
Journal:  Clin Med Res       Date:  2009-11-17

4.  Regulation of gap-junction protein connexin 43 by beta-adrenergic receptor stimulation in rat cardiomyocytes.

Authors:  Yi Xia; Kai-Zheng Gong; Ming Xu; You-Yi Zhang; Ji-Hong Guo; Yao Song; Ping Zhang
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

5.  β2-adrenergic stress evaluation of coronary endothelial-dependent vasodilator function in mice using (11)C-acetate micro-PET imaging of myocardial blood flow and oxidative metabolism.

Authors:  Etienne Croteau; Jennifer M Renaud; Christine Archer; Ran Klein; Jean N DaSilva; Terrence D Ruddy; Rob Sb Beanlands; Robert A deKemp
Journal:  EJNMMI Res       Date:  2014-12-16       Impact factor: 3.138

Review 6.  The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease.

Authors:  Marc L Decramer; Nicola A Hanania; Jan O Lötvall; Barbara P Yawn
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-01-25

Review 7.  Comparative safety and effectiveness of long-acting inhaled agents for treating chronic obstructive pulmonary disease: a systematic review and network meta-analysis.

Authors:  Andrea C Tricco; Lisa Strifler; Areti-Angeliki Veroniki; Fatemeh Yazdi; Paul A Khan; Alistair Scott; Carmen Ng; Jesmin Antony; Kelly Mrklas; Jennifer D'Souza; Roberta Cardoso; Sharon E Straus
Journal:  BMJ Open       Date:  2015-10-26       Impact factor: 2.692

8.  Propofol suppresses the His-ventricular conduction in paediatric patients.

Authors:  Mayuka Matsushima; Seishi Kimura; Atsuhiro Kitaura; Shinichi Hamasaki; Tatsushige Iwamoto; Takashi Mino; Kenichi Masui; Shinichi Nakao
Journal:  J Clin Pharm Ther       Date:  2020-10-24       Impact factor: 2.512

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.